Bioscience News - GEG Tech top picks
Curated by
BigField GEG Tech
Vaccine Breakthrough Infections with SARS-CoV-2 Variants | NEJM
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 - Nature
Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection - Nature Communication
Intranasal influenza vaccine spurs strong immune response in Phase 1 study
Axicabtagene Ciloleucel Approved in Japan for Relapsed/Refractory LBCL